Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer.
Burcombe RJ, Makris A, Richman PI, Daley FM, Noble S, Pittam M, Wright D, Allen SA, Dove J, Wilson GD.
Br J Cancer. 2005 Jan 17;92(1):147-55.PMID: 15611798 [PubMed - indexed for MEDLINE]Related articlesFree article